Boehringer Ingelheim is globl group of compnies embrcing mny cultures nd diverse societies.Reserch &; development hs been the foundtion of Boehringer Ingelheim’s success nd continues to be the mjor driver of innovtive, new medicines for the tretment of diseses with n unmet therpeutic need. Furthermore, in our constnt quest for phrmceuticl innovtion we hve successful ongoing collbortions nd re ctively seeking new collbortions with externl prtners, rnging from cdemic institutions to biophrmceuticl enterprises nd strt-up compnies.
